Israel Englander’s Pharming Group PHAR Stock Holding History

Israel Englander’s Portfolio PHAR Stock Details PHAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,385	Closed	-$360K	–	6220
2025 Q4	$360K	Buy	+20,385	New	+$321K	﹤0.01%	5144

Other funds holding PHAR

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SmartHarvest Portfolios Poulsbo, Washington $309M AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

NSG

Nalls Sherbakoff Group Knoxville, Tennessee $141M AUM 25.05% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LFG

Larson Financial Group St Louis, Missouri $3.81B AUM 32.31% 1-Year Est. Return

Israel Englander's PHAR Position: Q1 2026 in Review

Israel Englander sold out of Pharming Group (PHAR) in Q1 2026, closing a stake of 20,385 shares — an estimated $360K sold.

Israel Englander first reported a position in PHAR in Q4 2025 and held it in 1 quarter. The position peaked at $360K in Q4 2025. 13 funds tracked by Wall St. Rank hold PHAR as of Q1 2026.

Israel Englander reported no remaining Pharming Group position as of Q1 2026 after selling out during the quarter.
Israel Englander sold 20,385 Pharming Group shares in Q1 2026, an estimated $360K.
Israel Englander first reported a position in Pharming Group in Q4 2025 and held it in 1 quarter.
Israel Englander's Pharming Group position peaked at $360K in Q4 2025.
13 funds tracked by Wall St. Rank held Pharming Group as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.